BioCentury
ARTICLE | Company News

Photocure, Salix deal

January 7, 2013 8:00 AM UTC

Photocure received a $4.5 million milestone payment from Salix under a 2010 deal granting Salix exclusive, worldwide rights, excluding the Nordic region, to develop and commercialize Lumacan hexamino...